文献速递认知障碍与痴呆

脑脊液tau微管结合区变化可检测显性遗传性阿尔茨海默病的症状发作、认知下降、缠结和萎缩

Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.
PubMed 文献 · Ann Neurol · 2023-03-16

该研究对229例显性遗传性阿尔茨海默病(DIAD)突变携带者和130例非携带者进行横断面和纵向脑脊液分析,序贯检测N端/中域磷酸化tau、MTBR-tau种类、tau PET、其他可溶性tau和淀粉样蛋白生物标志物、临床认知评估及脑磁共振萎缩测量。结果显示,脑脊液MTBR-tau种类变化先于痴呆发作、tau缠结增加和萎缩,边界与核心种类比值与NFT病理和疾病进展相关。

要点

  • 脑脊液MTBR-tau边界区和核心区种类在症状前阶段升高、症状阶段降低。
  • 边界MTBR-tau与淀粉样病理和脑脊液p-tau相关,核心MTBR-tau与tau PET和神经退行性变指标相关更强。
  • 边界与核心种类比值持续增加,与临床进展和NFT相关。

核心结论

  • 脑脊液可溶性MTBR-tau种类变化先于DIAD痴呆发作、tau缠结增加和萎缩。
  • 4R特异性MTBR-tau(边界)与NFT(核心)MTBR-tau种类比值对应DIAD中NFT病理并随疾病进展变化。
  • 脑脊液不同MTBR-tau种类间的动态可能作为tau相关疾病进展和抗tau治疗靶点结合的标志物。

研究设计与样本

  • 研究纳入229例DIAD突变携带者和130例突变非携带者,采集横断面和纵向脑脊液。
  • 序贯检测N端/中域磷酸化tau、MTBR-tau种类、tau PET、其他可溶性tau和淀粉样蛋白生物标志物。
  • 同时进行综合临床和认知评估以及脑磁共振萎缩测量。

主要发现

  • 位于推定「边界」区的脑脊液MTBR-tau种类和一种对应神经原纤维缠结(NFT)聚集体「核心」区的种类在症状前阶段升高、症状阶段降低。
  • 「边界」MTBR-tau种类与淀粉样病理和脑脊液p-tau相关。
  • 「核心」MTBR-tau种类与tau PET和脑脊液神经退行性变指标相关更强。
  • 边界与核心种类比值提供持续增加的测量值,与临床进展和NFT相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Identifying cerebrospinal fluid measures of the microtubule binding region of tau (MTBR-tau) species that reflect tau aggregation could provide fluid biomarkers that track Alzheimer's disease related neurofibrillary tau pathological changes. We examined the cerebrospinal fluid (CSF) MTBR-tau species in dominantly inherited Alzheimer's disease (DIAD) mutation carriers to assess the association with Alzheimer's disease (AD) biomarkers and clinical symptoms. METHODS: Cross-sectional and longitudinal CSF from 229 DIAD mutation carriers and 130 mutation non-carriers had sequential characterization of N-terminal/mid-domain phosphorylated tau (p-tau) followed by MTBR-tau species and tau positron emission tomography (tau PET), other soluble tau and amyloid biomarkers, comprehensive clinical and cognitive assessments, and brain magnetic resonance imaging of atrophy. RESULTS: CSF MTBR-tau species located within the putative "border" region and one species corresponding to the "core" region of aggregates in neurofibrillary tangles (NFTs) increased during the presymptomatic stage and decreased during the symptomatic stage. The "border" MTBR-tau species were associated with amyloid pathology and CSF p-tau; whereas the "core" MTBR-tau species were associated stronger with tau PET and CSF measures of neurodegeneration. The ratio of the border to the core species provided a continuous measure of increasing amounts that tracked clinical progression and NFTs. INTERPRETATION: Changes in CSF soluble MTBR-tau species preceded the onset of dementia, tau tangle increase, and atrophy in DIAD. The ratio of 4R-specific MTBR-tau (border) to the NFT (core) MTBR-tau species corresponds to the pathology of NFTs in DIAD and change with disease progression. The dynamics between different MTBR-tau species in the CSF may serve as a marker of tau-related disease progression and target engagement of anti-tau therapeutics. ANN NEUROL 2023;93:1158-1172.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Horie K, Li Y, Barthélemy NR, et al. Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease. Ann Neurol. 2023. PMID: 36843330. doi:10.1002/ana.26620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。